Fibrosis–a common pathway to organ injury and failure
The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
Abstract
Fibrosis is a consequence of the inflammatory response. When fibrotic tissue becomes excessive, it can have diverse pathophysiological effects on a number of organ systems. The mechanisms underlying fibrosis and approaches to therapy are reviewed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hepatocyte injury, apoptosis and necrosis promote a sterile inflammatory response. This includes activation of KCs to clear necrotic debris, recruitment of lymphocytes and bone-marrow-derived monocytes, extracellular matrix (ECM) remodelling, myofibroblast activation, angiogenesis, and hepatocyte regeneration and differentiation to replace lost hepatocytes.11,31,32”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [31]
In the citing paper
“Both receptors are independently involved in regulation of cell adhesion, differentiation, proliferation of myofibroblasts and migration of both myofibroblasts and macrophages.31”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [31]
Citations
Cites
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,128
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Marcellin, P., Gane, E., Buti, M., Afdhal, N., Sievert, W., Jacobson, I. M., Washington, M. K., Germanidis, G., Flaherty, J. F., Schall, R. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61425-1 · Cited by 1,788
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Wynn, T. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31487 · Cited by 1,456
Cellular and molecular mechanisms of renal fibrosis
Liu, Y. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.149 · Cited by 1,446
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J.-D., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,360
Integrating mechanisms of pulmonary fibrosis
Wynn, T. A. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110551 · Cited by 1,274
Origin and function of myofibroblasts in kidney fibrosis
LeBleu, V. S., Taduri, G., O'Connell, J., Teng, Y., Cooke, V. G., Woda, C., Sugimoto, H., & Kalluri, R. (2013) · Nature Medicine · doi:10.1038/nm.3218 · Cited by 1,263
Heart repair by reprogramming non-myocytes with cardiac transcription factors
Song, K., Nam, Y.-J., Luo, X., Qi, X., Tan, W., Huang, G. N., Acharya, A., Smith, C. L., Tallquist, M. D., Neilson, E. G., et al. (2012) · Nature · doi:10.1038/nature11139 · Cited by 1,147
Self-citationSpinale, F. G. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2007 · Cited by 1,120
Hill, J. A., & Olson, E. N. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072139 · Cited by 1,065
Self-citationBardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
de Zeeuw, D., Akizawa, T., Audhya, P., Bakris, G. L., Chin, M., Christ-Schmidt, H., Goldsberry, A., Houser, M., Krauth, M., Lambers Heerspink, H. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306033 · Cited by 1,030
Rock, J. R., Barkauskas, C. E., Cronce, M. J., Xue, Y., Harris, J. R., Liang, J., Noble, P. W., & Hogan, B. L. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117988108 · Cited by 1,030
Signaling cross-talk between TGF-β/BMP and other pathways
Guo, X., & Wang, X.-F. (2009) · Cell Research · doi:10.1038/cr.2008.302 · Cited by 1,015
Henderson, N. C., Arnold, T. D., Katamura, Y., Giacomini, M. M., Rodriguez, J. D., McCarty, J. H., Pellicoro, A., Raschperger, E., Betsholtz, C., Ruminski, P. G., et al. (2013) · Nature Medicine · doi:10.1038/nm.3282 · Cited by 866
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis
Fingerlin, T. E., Murphy, E., Zhang, W., Peljto, A. L., Brown, K. K., Steele, M. P., Loyd, J. E., Cosgrove, G. P., Lynch, D., Groshong, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2609 · Cited by 809
Mechanisms of Pulmonary Fibrosis
Thannickal, V. J., Toews, G. B., White, E. S., Lynch III, J. P., & Martinez, F. J. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.103810 · Cited by 808
Pathological Ventricular Remodeling: Mechanisms: Part 1 of 2
Burchfield, J. S., Xie, M., & Hill, J. A. (2013) · Circulation · doi:10.1161/circulationaha.113.001878 · Cited by 766
Self-citationInflammatory processes in renal fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.114 · Cited by 690
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details
Umehara, H., Okazaki, K., Masaki, Y., Kawano, M., Yamamoto, M., Saeki, T., Matsui, S., Sumida, T., Mimori, T., Tanaka, Y., et al. (2012) · Modern Rheumatology · doi:10.3109/s10165-011-0508-6 · Cited by 680
Integrin–TGF‐β crosstalk in fibrosis, cancer and wound healing
Margadant, C., & Sonnenberg, A. (2010) · The EMBO Reports · doi:10.1038/embor.2009.276 · Cited by 653
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
Raghu, G., Brown, K. K., Bradford, W. Z., Starko, K., Noble, P. W., Schwartz, D. A., & King, T. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030511 · Cited by 652
Resident fibroblast lineages mediate pressure overload–induced cardiac fibrosis
Moore-Morris, T., Guimarães-Camboa, N., Banerjee, I., Zambon, A. C., Kisseleva, T., Velayoudon, A., Stallcup, W. B., Gu, Y., Dalton, N. D., Cedenilla, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74783 · Cited by 630
Wu, K. C., Weiss, R. G., Thiemann, D. R., Kitagawa, K., Schmidt, A., Dalal, D., Lai, S., Bluemke, D. A., Gerstenblith, G., Marbán, E., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.018 · Cited by 598
Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan: A Parallel, Randomized Trial
Raghu, G., Behr, J., Brown, K. K., Egan, J. J., Kawut, S. M., Flaherty, K. R., Martinez, F. J., Nathan, S. D., Wells, A. U., Collard, H. R., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-9-201305070-00003 · Cited by 553
Angiotensin II and Renal Fibrosis
Mezzano, S. A., Ruiz-Ortega, M., & Egido, J. (2001) · Hypertension · doi:10.1161/hy09t1.094234 · Cited by 523
Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis Clinical Research Network (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401739 · Cited by 505
Wong, T. C., Piehler, K., Meier, C. G., Testa, S. M., Klock, A. M., Aneizi, A. A., Shakesprere, J., Kellman, P., Shroff, S. G., Schwartzman, D. S., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.089409 · Cited by 493
Fallowfield, J. A., Mizuno, M., Kendall, T. J., Constandinou, C. M., Benyon, R. C., Duffield, J. S., & Iredale, J. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5288 · Cited by 479
Zeisberg, M., & Kalluri, R. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00328.2012 · Cited by 462
MUC5B Promoter Polymorphism and Interstitial Lung Abnormalities
Hunninghake, G. M., Hatabu, H., Okajima, Y., Gao, W., Dupuis, J., Latourelle, J. C., Nishino, M., Araki, T., Zazueta, O. E., Kurugol, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1216076 · Cited by 456
Variant in PNPLA3 is associated with alcoholic liver disease
Tian, C., Stokowski, R. P., Kershenobich, D., Ballinger, D. G., & Hinds, D. A. (2010) · Nature Genetics · doi:10.1038/ng.488 · Cited by 438
S. Antonopoulos, A., Margaritis, M., Lee, R., Channon, K., & Antoniades, C. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799504803 · Cited by 432
Hammel, P., Couvelard, A., O'Toole, D., Ratouis, A., Sauvanet, A., Fléjou, J. F., Degott, C., Belghiti, J., Bernades, P., Valla, D., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102083440604 · Cited by 427
Electrotonic Modulation of Cardiac Impulse Conduction by Myofibroblasts
Miragoli, M., Gaudesius, G., & Rohr, S. (2006) · Circulation Research · doi:10.1161/01.res.0000214537.44195.a3 · Cited by 390
Role of Lung Pericytes and Resident Fibroblasts in the Pathogenesis of Pulmonary Fibrosis
Hung, C., Linn, G., Chow, Y.-H., Kobayashi, A., Mittelsteadt, K., Altemeier, W. A., Gharib, S. A., Schnapp, L. M., & Duffield, J. S. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201212-2297oc · Cited by 385
Inhibiting MicroRNA-192 Ameliorates Renal Fibrosis in Diabetic Nephropathy
Putta, S., Lanting, L., Sun, G., Lawson, G., Kato, M., & Natarajan, R. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011050485 · Cited by 368
Portal Hypertension and Its Complications
Sanyal, A. J., Bosch, J., Blei, A., & Arroyo, V. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.007 · Cited by 358
Hepatocytes Do Not Undergo Epithelial-Mesenchymal Transition in Liver Fibrosis in Mice
Taura, K., Miura, K., Iwaisako, K., Österreicher, C. H., Kodama, Y., Penz-Österreicher, M., & Brenner, D. A. (2010) · Hepatology · doi:10.1002/hep.23368 · Cited by 336
SPACH, M. S., & BOINEAU, J. P. (1997) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1997.tb06199.x · Cited by 329
Colchicine in the Treatment of Cirrhosis of the Liver
Kershenobich, D., Vargas, F., Garcia-Tsao, G., Tamayo, R. P., Gent, M., & Rojkind, M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182602 · Cited by 328
Eradication of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis C
Maylin, S., Martinot–Peignoux, M., Moucari, R., Boyer, N., Ripault, M., Cazals–Hatem, D., Giuily, N., Castelnau, C., Cardoso, A. C., Asselah, T., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.044 · Cited by 321
The RAAS in the pathogenesis and treatment of diabetic nephropathy
Ruggenenti, P., Cravedi, P., & Remuzzi, G. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.58 · Cited by 319
Pirfenidone for Diabetic Nephropathy
Sharma, K., Ix, J. H., Mathew, A. V., Cho, M., Pflueger, A., Dunn, S. R., Francos, B., Sharma, S., Falkner, B., McGowan, T. A., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010101049 · Cited by 319
Tanaka, K., Zlochiver, S., Vikstrom, K. L., Yamazaki, M., Moreno, J., Klos, M., Zaitsev, A. V., Vaidyanathan, R., Auerbach, D. S., Landas, S., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.153858 · Cited by 319
Eron, J. J., Young, B., Cooper, D. A., Youle, M., DeJesus, E., Andrade-Villanueva, J., Workman, C., Zajdenverg, R., Fätkenheuer, G., Berger, D. S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62041-9 · Cited by 317
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease
Fouts, D. E., Torralba, M., Nelson, K. E., Brenner, D. A., & Schnabl, B. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.019 · Cited by 311
A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C†
Huang, H., Shiffman, M. L., Friedman, S., Venkatesh, R., Bzowej, N., Abar, O. T., Rowland, C. M., Catanese, J. J., Leong, D. U., Sninsky, J. J., et al. (2007) · Hepatology · doi:10.1002/hep.21695 · Cited by 297
Myofibroblasts Induce Ectopic Activity in Cardiac Tissue
Miragoli, M., Salvarani, N., & Rohr, S. (2007) · Circulation Research · doi:10.1161/circresaha.107.160549 · Cited by 297
Berenguer, J., Álvarez‐Pellicer, J., Martín, P. M., López‐Aldeguer, J., Von‐Wichmann, M. A., Quereda, C., Mallolas, J., Sanz, J., Tural, C., Bellón, J. M., et al. (2009) · Hepatology · doi:10.1002/hep.23020 · Cited by 295
The role of EMT in renal fibrosis
Carew, R. M., Wang, B., & Kantharidis, P. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1227-1 · Cited by 294
Reversibility of Hepatic Fibrosis in Autoimmune Hepatitis
Dufour, J.-F., DeLellis, R., & Kaplan, M. M. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-11-199712010-00006 · Cited by 290
Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis
Sakai, & Tager, A. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.001 · Cited by 285
EGFR Signaling Promotes TGFβ-Dependent Renal Fibrosis
Chen, J., Chen, J.-K., Nagai, K., Plieth, D., Tan, M., Lee, T.-C., Threadgill, D. W., Neilson, E. G., & Harris, R. C. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011070645 · Cited by 285
Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial
Raghu, G., Million-Rousseau, R., Morganti, A., Perchenet, L., Behr, J., & the MUSIC Study Group (2013) · European Respiratory Journal · doi:10.1183/09031936.00104612 · Cited by 277
Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo.
Rockey, D. C., Housset, C. N., & Friedman, S. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116769 · Cited by 268
Self-citationTzouvelekis, A., Paspaliaris, V., Koliakos, G., Ntolios, P., Bouros, E., Oikonomou, A., Zissimopoulos, A., Boussios, N., Dardzinski, B., Gritzalis, D., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-171 · Cited by 255
Zhou, W., Otto, E. A., Cluckey, A., Airik, R., Hurd, T. W., Chaki, M., Diaz, K., Lach, F. P., Bennett, G. R., Gee, H. Y., et al. (2012) · Nature Genetics · doi:10.1038/ng.2347 · Cited by 243
Goldbach‐Mansky, R., Shroff, S. D., Wilson, M., Snyder, C., Plehn, S., Barham, B., Pham, T., Pucino, F., Wesley, R. A., Papadopoulos, J. H., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23620 · Cited by 229
Endothelin—Biology and disease
Khimji, A.-K., & Rockey, D. C. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.05.002 · Cited by 222
Self-citationCan We Target Tubular Damage to Prevent Renal Function Decline in Diabetes?
Bonventre, J. V. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.07.008 · Cited by 219
Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis
Lakner, A. M., Steuerwald, N. M., Walling, T. L., Ghosh, S., Li, T., McKillop, I. H., Russo, M. W., Bonkovsky, H. L., & Schrum, L. W. (2012) · Hepatology · doi:10.1002/hep.25613 · Cited by 204
Potential approaches to reverse or repair renal fibrosis
Tampe, D., & Zeisberg, M. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.14 · Cited by 195
Current status of novel antifibrotic therapies in patients with chronic liver disease
Cohen-Naftaly, M., & Friedman, S. L. (2011) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x11413002 · Cited by 186
Giannetta, E., Isidori, A. M., Galea, N., Carbone, I., Mandosi, E., Vizza, C. D., Naro, F., Morano, S., Fedele, F., & Lenzi, A. (2012) · Circulation · doi:10.1161/circulationaha.111.063412 · Cited by 185
Vadasz, Z., Kessler, O., Akiri, G., Gengrinovitch, S., Kagan, H. M., Baruch, Y., Izhak, O. B., & Neufeld, G. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.052 · Cited by 182
Mechanisms of skin fibrosis in systemic sclerosis
JINNIN, M. (2010) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2009.00738.x · Cited by 173
Santiago, B., Gutierrez-Cañas, I., Dotor, J., Palao, G., Lasarte, J. J., Ruiz, J., Prieto, J., Borrás-Cuesta, F., & Pablos, J. L. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23859.x · Cited by 171
Renal epithelial injury and fibrosis
Kaissling, B., LeHir, M., & Kriz, W. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.02.010 · Cited by 167
Apoptosis and angiogenesis: an evolving mechanism for fibrosis
Johnson, A., & DiPietro, L. A. (2013) · The FASEB Journal · doi:10.1096/fj.12-214189 · Cited by 160
Cigna, N., Moshai, E. F., Brayer, S., Marchal-Sommé, J., Wémeau-Stervinou, L., Fabre, A., Mal, H., Lesèche, G., Dehoux, M., Soler, P., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.08.019 · Cited by 154
Imatinib mesylate treatment of nephrogenic systemic fibrosis
Kay, J., & High, W. A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23696 · Cited by 150
Kosmala, W., Przewłocka‐Kosmala, M., Szczepanik-Osadnik, H., Mysiak, A., O'Moore‐Sullivan, T. M., & Marwick, T. H. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.08.014 · Cited by 142
Antagonists of Aldosterone and Proteinuria in Patients With CKD: An Uncontrolled Pilot Study
Bianchi, S., Bigazzi, R., & Campese, V. M. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.03.007 · Cited by 140
Nephrogenic Systemic Fibrosis, Gadolinium, and Iron Mobilization
Swaminathan, S., Horn, T. D., Pellowski, D., Abul-Ezz, S., Bornhorst, J. A., Viswamitra, S., & Shah, S. V. (2007) · New England Journal of Medicine · doi:10.1056/nejmc070248 · Cited by 122
Expression of the Integrin α8β1 during Pulmonary and Hepatic Fibrosis
Levine, D., Rockey, D. C., Milner, T. A., Breuss, J. M., Fallon, J. T., & Schnapp, L. M. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65066-3 · Cited by 115
Self-citationMacrophages: Central regulators of hepatic fibrogenesis and fibrosis resolution
Ramachandran, P., & Iredale, J. P. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.026 · Cited by 113
Pockros, P. J., Jeffers, L., Afdhal, N., Goodman, Z. D., Nelson, D., Gish, R. G., Reddy, R. K., Reindollar, R., Rodriguez-Torres, M., Sullivan, S., et al. (2007) · Hepatology · doi:10.1002/hep.21561 · Cited by 111
The Glial Scar-Monocyte Interplay: A Pivotal Resolution Phase in Spinal Cord Repair
Shechter, R., Raposo, C., London, A., Sagi, I., & Schwartz, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027969 · Cited by 110
Du, X., Shimizu, A., Masuda, Y., Kuwahara, N., Arai, T., Kataoka, M., Uchiyama, M., Kaneko, T., Akimoto, T., Iino, Y., et al. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.68 · Cited by 109
Thalidomide Prevents Bleomycin-Induced Pulmonary Fibrosis in Mice
Tabata, C., Tabata, R., Kadokawa, Y., Hisamori, S., Takahashi, M., Mishima, M., Nakano, T., & Kubo, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.708 · Cited by 107
Vespasiani‐Gentilucci, U., Carotti, S., Perrone, G., Mazzarelli, C., Galati, G., Onetti‐Muda, A., Picardi, A., & Morini, S. (2015) · Liver International · doi:10.1111/liv.12531 · Cited by 99
Rapamycin Prevents Transforming Growth Factor-α–Induced Pulmonary Fibrosis
Korfhagen, T. R., Le Cras, T. D., Davidson, C. R., Schmidt, S. M., Ikegami, M., Whitsett, J. A., & Hardie, W. D. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0377oc · Cited by 97
Pivotal role of pericytes in kidney fibrosis
Kida, Y., & Duffield, J. S. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05531.x · Cited by 96
Searching for MiR-acles in Cardiac Fibrosis
van Rooij, E., & Olson, E. N. (2009) · Circulation Research · doi:10.1161/circresaha.108.192492 · Cited by 94
Huang, S. K., Scruggs, A. M., McEachin, R. C., White, E. S., & Peters-Golden, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107055 · Cited by 93
Farglitazar Lacks Antifibrotic Activity in Patients With Chronic Hepatitis C Infection
McHutchison, J. G., Goodman, Z. D., Patel, K., Makhlouf, H. R., Rodriguez‐Torres, M., Shiffman, M. L., Rockey, D. C., Husa, P., Chuang, W., Levine, R. A., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.12.003 · Cited by 91
Self-citationCardiovascular Effects of Glucagonlike peptide–1 Agonists
Davidson, M. H. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.046 · Cited by 88
Translating an Understanding of the Pathogenesis of Hepatic Fibrosis to Novel Therapies
Rockey, D. C. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.01.005 · Cited by 79
Self-citationKuhn, A., Haust, M., Ruland, V., Weber, R., Verde, P. E., Felder, G., Ohmann, C., Gensch, K., & Ruzicka, T. (2010) · Rheumatology · doi:10.1093/rheumatology/keq077 · Cited by 79
Kim, M. Y., Cho, M.-Y., Baik, S. K., Jeong, P. H., Suk, K. T., Jang, Y. O., Yea, C. J., Kim, J. W., Kim, H. S., Kwon, S. O., et al. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02774.x · Cited by 74
Russo, R. C., Garcia, C. C., Barcelos, L. S., Rachid, M. A., Guabiraba, R., Roffê, E., Souza, A. L. S., Sousa, L. P., Mirolo, M., Doni, A., et al. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0610346 · Cited by 73
Morgan, T. R. M., Weiss, D. G., Nemchausky, B. A., Schiff, E. R., Anand, B., Simon, F. R., Kidao, J., Cecil, B. D., Mendenhall, C. L., Nelson, D. B., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.057 · Cited by 71
Sirolimus Therapy of Focal Segmental Glomerulosclerosis Is Associated With Nephrotoxicity
Cho, M. E., Hurley, J. K., & Kopp, J. B. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.10.020 · Cited by 69
Reversal of cirrhosis: An achievable goal of hepatitis B antiviral therapy
Liaw, Y. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.05.007 · Cited by 69
Investigational drugs targeting cardiac fibrosis
Roubille, F., Busseuil, D., Merlet, N., Kritikou, E. A., Rhéaume, É., & Tardif, J. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.839942 · Cited by 67
Cardiac Intercellular Communication: Are Myocytes and Fibroblasts Fair-Weather Friends?
Martin, M. L., & Blaxall, B. C. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9404-5 · Cited by 67
Stem cell transplantation as a therapy for cardiac fibrosis
Elnakish, M. T., Kuppusamy, P., & Khan, M. (2012) · The Journal of Pathology · doi:10.1002/path.4111 · Cited by 62
Interferon gamma‐1b for the treatment of fibrosis in chronic hepatitis C infection
Muir, A. J., Sylvestre, P. B., & Rockey, D. C. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00689.x · Cited by 62
Self-citationImproving the efficacy of RAAS blockade in patients with chronic kidney disease
Heerspink, H. J. L., de Borst, M. H., Bakker, S. J. L., & Navis, G. J. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.281 · Cited by 59
Guney, I., Selcuk, N. Y., Altintepe, L., Atalay, H., Başarali, M. K., & Büyükbaş, S. (2009) · Renal Failure · doi:10.3109/08860220903150312 · Cited by 59
Massare, J. E., Berry, J. M., LUO, X., ROB, F., Johnstone, J. L., Shelton, J. M., Bassel‐Duby, R., Hill, J. A., & Naseem, R. H. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01736.x · Cited by 38
Self-citationPulmonary Fibrosis, Bone Marrow Failure, and Telomerase Mutation
Gansner, J. M., Rosas, I. O., & Ebert, B. L. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1200999 · Cited by 29
The efficacy of minocycline against methotrexate-induced pulmonary fibrosis in mice.
Kalemci, S., Dirican, N., Çetin, E. S., Sözen, H., Üner, A. G., Yaylalı, A., Aksun, S., Karaçam, V., Ulger, E., Sütçü, R., et al. (2013) · PubMed · Cited by 19
Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study: Table 1–
Crestani, B., Chapron, J., Wallaert, B., Bergot, E., Delaval, P., Israël‐Biet, D., Lacronique, J., Monnet, I., Reynaud‐Gaubert, M., Tazi, A., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00113011 · Cited by 17
Priante, G., Musacchio, E., Valvason, C., Clari, G., Bordin, L., Sartori, L., & Baggio, B. (2012) · Journal of Nephrology · doi:10.5301/jn.5000193 · Cited by 14
Dimas, V., Ayers, C. R., Daniels, J. D., Joglar, J. A., Hill, J. A., & Naseem, R. H. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02888.x · Cited by 13
Self-citationAntifibrotics for Chronic Hepatitis C
Pockros, P. J. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.05.005 · Cited by 2
Research works printed but not linked: 1
- TORAFIC Investigators Group, 2011, Clin Ther, 33, 1204.e3
Cited by
Aran, D., Looney, A. P., Liu, L., Wu, E., Fong, V., Hsu, A., Chak, S., Naikawadi, R. P., Wolters, P. J., Abate, A. R., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0276-y · Cited by 4,984
“This process was performed iteratively using only the top cell types from the previous step and the variable genes among them until only one cell type remained (for details see Methods, Supplementary Information 1 and the SingleR Github repository at https://github.com/dviraran/SingleR ).”
InfluentialRicheldi, L., Collard, H. R., & Jones, M. G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30866-8 · Cited by 2,020
Hepatic stellate cells as key target in liver fibrosis
Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485
Mechanobiology of YAP and TAZ in physiology and disease
Panciera, T., Azzolin, L., Cordenonsi, M., & Piccolo, S. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.87 · Cited by 1,461
Macrophages: versatile players in renal inflammation and fibrosis
Tang, P. M.-K., Nikolic-Paterson, D. J., & Lan, H.-Y. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0110-2 · Cited by 1,033
Metadata
- Authors
- Rockey, D. C., Bell, P. D., & Hill, J. A.
- Affiliations
- Medical University of South Carolina (US)
- The University of Texas Southwestern Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-03-19
- Volume
- 372
- Issue
- 12
- Pages
- 1138-1149
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1977437151
- Cited by
- 1,428
- References
- 118
- Citations by year
- 2026: 104 · 2025: 116 · 2024: 154 · 2023: 149 · 2022: 162 · 2021: 162 · 2020: 152 · 2019: 118 · 2018: 96 · 2017: 94 · 2016: 85 · 2015: 33
- FWCI
- 14.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- fibrosis, organ damage, organ failure, inflammation, fibrosis mechanisms, fibrosis treatment
- MeSH terms
- Fibrosis, Humans, Multiple Organ Failure, Transforming Growth Factor beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.